Neuroimaging standards for research into small vessel disease—advances since 2013Marco Duering, Hugh S. Markus, Natalia S. Rost et al.|The Lancet Neurology|2023Cited by 962
Implementation of subjective cognitive decline criteria in research studiesJosé Luís Molinuevo, Laura A. Rabin, Rebecca E. Amariglio et al.|Alzheimer s & Dementia|2016Cited by 589
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementiaMichael Ewers, Harald Hampel, Reisa A. Sperling et al.|Trends in Neurosciences|2011Cited by 358
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s diseaseAlexa Pichet Binette, Virginia Lee, Nicolai Franzmeier et al.|Nature Communications|2022Cited by 129
CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s DiseaseJeremy Koppel, Philippe Marambaud, Fabien Campagne et al.|Molecular Medicine|2011Cited by 27